Topical antibiotics pharmaceuticals are used to treat infections of the skin and are commonly applied as creams and ointments. Antibiotics are agents that destroy or inhibit the growth of microorganisms, which are sensitive to them. Few topical antibiotics are sold without prescription from physicians and are available in several forms such as ointments, creams, sprays and powders. Topical antibiotics prevents infection caused by bacteria which get into minor scrapes, burns, and cuts. Treating minor injuries with antibiotics allows faster healing. If the injuries are left untreated, the bacteria will multiply and create redness, itching, swelling, oozing, and causing pain. Untreated infections can ultimately spread and become more serious. Soft tissue and dermal bacterial infections are one of the most commonly occurring conditions amongst people accounting for over 25 million visits to physicians every year. Most of these infections are minor and chronic in nature causing irritation and can be treated as outpatient procedures. Topical antibiotics are a large generic group of pharmaceutical products catering to the treatment of these commonly occurring conditions. A large variety of bacteria such as Staph aureus, Streptococcus viridians, Enterococcus faecalis and Staph pyogenes are responsible for these infections.
This report contains market size and forecasts of Topical Antibiotics in global, including the following market information:
Global Topical Antibiotics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Topical Antibiotics Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Topical Antibiotics companies in 2021 (%)
The global Topical Antibiotics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ointments Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Topical Antibiotics include Novartis AG, GlaxoSmithKline plc, Perrigo Company plc, Pfizer, Inc, Almirall, S.A., Bausch Health Companies, Inc, Medimetriks Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. and Mayne Pharma Group Limited.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Topical Antibiotics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Topical Antibiotics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Topical Antibiotics Market Segment Percentages, by Type, 2021 (%)
Ointments
Creams
Powder
Gels
Others
Global Topical Antibiotics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Topical Antibiotics Market Segment Percentages, by Application, 2021 (%)
Skin Infection
Eye Infection
Bromhidrosis
Others
Global Topical Antibiotics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Topical Antibiotics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Topical Antibiotics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Topical Antibiotics revenues share in global market, 2021 (%)
Key companies Topical Antibiotics sales in global market, 2017-2022 (Estimated), (MT)
Key companies Topical Antibiotics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
GlaxoSmithKline plc
Perrigo Company plc
Pfizer, Inc
Almirall, S.A.
Bausch Health Companies, Inc
Medimetriks Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd.
Mayne Pharma Group Limited.